Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Study Links ADT Cancer Treatment to Increased Risk of Dementia

Oct 24, 2016
Serious Recall Label on Medtronic Heartware HVAD Issue

Study Found that ADT Treatment Increased Risk of Dementia

A study published in JAMA Oncology found that androgen deprivation therapy (ADT), which is a treatment used for men with prostate cancer, may be associated with an increased risk of dementia. Researchers were led by Kevin T. Nead, MD, of Stanford University School of Medicine. "ADT has a demonstrated survival benefit in some patients with prostate cancer. However, it also has been linked to several adverse health effects," said Dr. Nead, according to Cancer Network. "A growing body of evidence supports a link between ADT and cognitive dysfunction, including Alzheimer disease."

Researchers analyzed medical records of 9,272 men with prostate cancer not previously diagnosed with dementia between 1994 and 2013. ADT treatment was used in 1,826 patients. The average age of men in the study was 66.8 years. The majority (58.8%) of the study cohort was white. Researchers found that ADT use was linked to an increased risk of dementia.

Dementia Was Diagnosed After Using ADT

A total of 314 cases of dementia were diagnosed after a median follow-up of 3.4 years. The link between ADT use and dementia was statistically significant. Dementia was diagnosed at a median time of 4 years. In men using ADT, the risk of dementia after 5 years was 7.9% compared to 3.5% in men not using ADT. The greatest risk was among men who received ADT for at least 12 months. When authors excluded patients with chemotherapy, they had similar findings. "We show a dose response effect between greater duration of use of ADT and increased risk of dementia. Finally, we find that use of ADT increases the risk of dementia regardless of age, but that older men receiving ADT were the least likely to remain dementia free," authors said.

"This finding should be investigated in prospective studies given significant individual patient and health system implications if there are higher rates of dementia among the large group of patients undergoing ADT," authors stated.

Parker | Waichman Logo Legal Help from Parker Waichman LLP
For a free lawsuit evaluation with an attorney, please fill out our online form, or call 1-800-YOURLAWYER (1-800-968-7529) today. Click Here to be redirected to our home page to browse through our thousands of articles and various practice areas.
 

Need Legal Help Regarding ADT Cancer Treatment

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

 


Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo